½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1559165

¼¼°èÀÇ RNA ½ÃÄö½Ì : °¢Á¾ ±â¼ú°ú ½ÃÀå

RNA Sequencing: Technologies and Global Markets

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BCC Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 166 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è RNA ½ÃÄö½Ì ½ÃÀå ±Ô¸ð´Â 2024³â 43¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 19.1%·Î ÃßÀ̵Ǹç 2029³â ¸»¿¡´Â 103¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

°ø±¸ ¹× ½Ã¾à ºÎ¹®Àº 2024³â 30¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÌ°í, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 19.6%·Î ÃßÀÌÇßÀ¸¸ç 2029³â ¸»¿¡´Â 74¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ Àåºñ ºÎ¹®Àº 2024³â 6¾ï 4,560¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÌ°í, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 18.2%·Î ÃßÀ̵Ǹç 2029³â ¸»¿¡´Â 15¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è RNA ½ÃÄö½Ì ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ¹ý±Ô ȯ°æ, ½Å±â¼ú ¹× ±â¼ú °³¹ß µ¿Çâ, ½ÃÀå ±Ô¸ð ÃßÀÌ ¹× ¿¹Ãø, °¢Á¾ ±¸ºÐ ¹× Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå Àü¸Á
  • Á¶»ç ¹üÀ§
  • ½ÃÀå °³¿ä

Á¦2Àå ½ÃÀå °³¿ä

  • °³¿ä
  • ±â¼ú ¹è°æ
  • Àü»çüÇÐ ±â¼ú
  • Àü»çüÇи¦ À§ÇÑ RNA ½ÃÄö½Ì
  • RNA-SeqÀÇ ½ÇÇèÀû ¿öÅ©Ç÷οì
  • RNA-Seq ¿öÅ©ÇÃ·Î¿ì °í·Á »çÇ×
  • RNA ½ÃÄö½Ì¿¡ ÀûÇÕÇÑ Ç÷§ÆûÀ» ¼±ÅÃÇÏ´Â ÀýÂ÷
  • ±ÔÁ¦ »óȲ
  • ¼ºÀå Àü·« Á¦¾È

Á¦3Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • µ¥ÀÌÅÍ ºÐ¼® ´É·ÂÀÇ ±Þ¼ÓÇÑ Áøº¸
  • À¯ÀüüÇÐ¿Í ¹ÙÀÌ¿ÀÀÇ·á ¿¬±¸¿¡ ´ëÇÑ ¹Ù¶÷Á÷ÇÑ ÀÚ±Ý Á¶´Þ ½Ã³ª¸®¿À
  • À¯Àüü ½ÃÄö½Ì °¡°Ý ÀúÇÏ
  • ¾Ï ÀÌȯÀ² Áõ°¡¿¡ ÀÇÇÑ ¸ÂÃãÇü Ä¡·á ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • µ¥ÀÌÅÍ Ç¥ÁØÈ­ÀÇ ºÎÁ·
  • ÄÚ½ºÆ®¿Í Ä¿¹ö¸®ÁöÀÇ °úÁ¦
  • ½ÃÀå ±âȸ
  • ºí·ÏüÀΰú Ŭ¶ó¿ìµå ÄÄÇ»Æà ±â¼úÀÇ È°¿ë
  • RNAÀÇ ºÐ¸® ¹× ÃßÃâ °úÁ¤¿¡¼­ÀÇ ±â¼úÀû Áøº¸

Á¦4Àå ½Å±â¼ú°ú °³¹ß

  • ´ÜÀÏ ¼¼Æ÷ RNA ½ÃÄö½Ì
  • ±âŸ »õ·Î¿î ´ÜÀÏ ¼¼Æ÷ ±â¼ú

Á¦5Àå ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®

  • ÁÖ¿ä ½ÃÀå µ¿Çâ
  • ¼¼ºÐÈ­ÀÇ ³»¿ª
  • ¼¼°èÀÇ RNA ½ÃÄö½Ì ½ÃÀå :Á¦Ç°º°
  • ±â±â
  • Åø?½Ã¾à
  • ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º
  • ¼¼°è RNA ½ÃÄö½Ì ½ÃÀå : ±â¼úº°
  • ÇÕ¼º¿¡ ÀÇÇÑ ½ÃÄö½Ì
  • ÀÌ¿Â Å䷻Ʈ ¹ÝµµÃ¼ ½ÃÄö½Ì
  • ´ÜÀÏ ºÐÀÚ ½Ç½Ã°£ ½ÃÄö½Ì
  • ³ª³ëÆ÷¾î ½ÃÄö½Ì
  • ¼¼°èÀÇ RNA ½ÃÄö½Ì ½ÃÀå : ¿ëµµº°
  • ¹ßÇö ÇÁ·ÎÆÄÀϸµ Çؼ®
  • small RNA ½ÃÄö½Ì
  • De Novo Æ®·£½ºÅ©¸³Æ® ¾î¼Àºí¸®
  • Variant Call°ú Transcriptome Èļº
  • ¼¼°è RNA ½ÃÄö½Ì ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°
  • Çмú¿¬±¸±â°ü
  • Á¦¾à,¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ÀÓ»ó ½ÇÇè½Ç,º´¿ø ½ÇÇè½Ç
  • ±âŸ
  • Áö¸®Àû ³»¿ª
  • ¼¼°èÀÇ RNA ½ÃÄö½Ì ½ÃÀå :Áö¿ªº°
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦6Àå °æÀï Á¤º¸

  • °³¿ä
  • ÁÖ¿ä ±â¾÷ÀÇ ·©Å·
  • ±â¾÷ÀÇ Ã¤¿ë Àü·«
  • Çù¾÷°ú °è¾à
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ÆÄÆ®³Ê½Ê
  • È®Àå
  • M&A
  • RNA ½ÃÄö½ÌÀÇ µ¥ÀÌÅÍ »ý¼º¿¡ À־ÀÇ CROÀÇ ¿ªÇÒ
  • ÁÖ¿ä RNA ½ÃÄö½Ì ¼­ºñ½º Á¦°ø¾÷ü

Á¦7Àå RNA ½ÃÄö½Ì ½ÃÀåÀÇ Áö¼Ó°¡´É¼º: ESG °üÁ¡

  • ESG: ¼Ò°³
  • ½ÃÀå¿¡¼­ ESG ¼º´É
  • RNA ½ÃÄö½Ì ¾÷°è¿¡¼­ ESG ½Ç½À
  • ȯ°æ ¼º´É
  • »çȸÀû ¼º´É
  • °Å¹ö³Í½º ÆÛÆ÷¸Õ½º
  • BCC¿¡ ÀÇÇÑ ÃÑ·Ð

Á¦8Àå ºÎ·Ï

  • Á¶»ç ¹æ¹ý
  • Âü°í¹®Çå
  • ¾à¾î
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
  • 10X GENOMICS
  • AGILENT TECHNOLOGIES INC.
  • BECKMAN COULTER INC.(SUBSIDIARY OF DANAHER CORP.)
  • BIO-RAD LABORATORIES INC.
  • BGI
  • F. HOFFMANN-LA ROCHE LTD.
  • ILLUMINA INC.
  • INTEGRATED DNA TECHNOLOGIES INC.
  • MICROSYNTH AG
  • OXFORD NANOPORE TECHNOLOGIES PLC.
  • QIAGEN
  • REVVITY
  • STANDARD BIOTOOLS
  • THERMO FISHER SCIENTIFIC INC.
BJH 24.09.30

The global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.1% during the forecast period of 2024 to 2029.

The global market for tools and reagents for RNA sequencing is expected to grow from $3.0 billion in 2024 and is projected to reach $7.4 billion by the end of 2029, at a CAGR of 19.6% during the forecast period of 2024 to 2029.

The global market for instruments for RNA sequencing is expected to grow from $645.6 million in 2024 and is projected to reach $1.5 billion by the end of 2029, at a CAGR of 18.2% during the forecast period of 2024 to 2029.

Report Scope:

This research report covers the global market for RNA sequencing. It incorporates an in-depth analysis of the RNA sequencing market, including market estimates and trends through 2029. For this analysis, the market has been segmented based on products, technologies, applications, end users and regions. In terms of geographical region, the market is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for the base year 2023, with forecasts for 2024 through 2029.

This report also examines strategies and collaborations, discusses the regulatory landscape and analyzes macroeconomic factors when considering new technologies, the industry's growing competition and changing customer needs. It also includes various analytical frameworks, such as ESG analysis, competitive analysis and strategic recommendations, that will help companies operating within this market devise their strategic plan of action.

Report Includes:

  • 65 data tables and 57 additional tables
  • A review of the global market and technologies for RNA sequencing
  • Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • Evaluation of the overall market for RNA sequencing, and corresponding market share analysis by product, technology, application, end-user and region
  • Discussion of recent RNA sequencing approaches such as next-generation sequencing (NGS) technology, single nucleotide polymorphism (SNP) discovery, RNA editing, and Sanger sequencing technology
  • Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
  • Analysis of the regulatory landscape and macroeconomic factors impacting the market
  • Coverage of the most recent approvals, recalls, safety alerts and clinical trials
  • Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings, and consumer attitudes
  • Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
  • Profiles of the leading companies, including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., and Qiagen

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • Technology Background
  • Transcriptomics Technologies
  • RNA Sequencing for Transcriptomics
  • RNA-Seq Experimental Workflow
  • RNA-Seq Workflow Considerations
  • Steps to Select the Right Platform for RNA Sequencing
  • Regulatory Landscape
  • Growth Strategy Recommendations

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Rapid Advances in Data Analysis Capabilities
  • Favorable Funding Scenario for Genomics and Biomedical Research Activities
  • Decline in the Prices of Genome Sequencing
  • Growing Prevalence of Cancer Generating Demand for Personalized Treatments
  • Market Restraints
  • Lack of Data Standardization
  • Cost vs. Coverage Challenges
  • Market Opportunities
  • Harnessing Blockchain and Cloud Computing Technologies
  • Technological Advances in RNA Isolation and Extraction Processes

Chapter 4 Emerging Technologies and Developments

  • Single-Cell RNA Sequencing
  • Other Emerging Single-Cell Technologies

Chapter 5 Market Segmentation Analysis

  • Key Market Trends
  • Segmentation Breakdown
  • Global Market for RNA Sequencing by Product
  • Instruments
  • Tools and Reagents
  • Software and Services
  • Global Market for RNA Sequencing by Technology
  • Sequencing by Synthesis
  • Ion Torrent Semiconductor Sequencing
  • Single-Molecule Real-Time Sequencing
  • Nanopore Sequencing
  • Global Market for RNA Sequencing by Application
  • Expression Profiling Analysis
  • Small RNA Sequencing
  • De Novo Transcriptome Assembly
  • Variant Calling and Transcriptome Epigenetics
  • Global Market for RNA Sequencing by End User
  • Academic Research Organizations
  • Pharmaceutical and Biotechnology Companies
  • Clinical and Hospital Laboratories
  • Other End Users
  • Geographic Breakdown
  • Global RNA Sequencing Market by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 6 Competitive Intelligence

  • Overview
  • Ranking of Leading Market Players
  • Key Strategies Adopted by Players
  • Collaborations and Agreements
  • New Product Launches
  • Partnerships
  • Expansions
  • Mergers and Acquisitions
  • The Role of CROs in RNA Sequencing Data Generation
  • Leading RNA Sequencing Service Providers

Chapter 7 Sustainability in RNA Sequencing Market: ESG Perspective

  • Introduction to ESG
  • ESG Performance in the Market
  • ESG Practices in the RNA Sequencing Industry
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • Concluding Remarks from BCC Research

Chapter 8 Appendix

  • Methodology
  • References
  • Acronyms
  • Company Profiles
  • 10X GENOMICS
  • AGILENT TECHNOLOGIES INC.
  • BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
  • BIO-RAD LABORATORIES INC.
  • BGI
  • F. HOFFMANN-LA ROCHE LTD.
  • ILLUMINA INC.
  • INTEGRATED DNA TECHNOLOGIES INC.
  • MICROSYNTH AG
  • OXFORD NANOPORE TECHNOLOGIES PLC.
  • QIAGEN
  • REVVITY
  • STANDARD BIOTOOLS
  • THERMO FISHER SCIENTIFIC INC.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦